FDA
- Status: approved
Induction of labor with PGE2 (Induction of labor with PGE2) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Guangzhou Women and Children's Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.